Replies to post #370392 on Anavex Life Sciences Corp (AVXL)

[raja48185]

I am waiting for the first (AVXL )FDA approval and believe that will be the real catalyst.

AD data (full and ready to be shared with the rest of the world ) will probably be ready late 2H of 2022. Quality of data matters and meeting primary outcomes/goals is going to be key. We will know if it is a game-winning Home Run or if the game is to be extended for another innings or two. At this point in time, my optimistic view is 'hoping for the best'.

JMHO.

[Hoskuld]

Absolutely: there are several huge events coming. Rett trial results will be great - but we have P3 AD trial results and PD OL P2 results prior to top line release of the P3 trial. I am very, very excited about the next 3 months.

[poonch1ne]

I like it, deals anytime, I like it.

[tredenwater2]

The bidding war will be to say the least, intense. We’ve waited a long time for this. Buckle up.

Amen Gambit, Amen! Dr. Missling is not rushing around trying to raise the price per share for impatient investors but rather preparing for the mother of all news to be released, the TLD for Alzheimer’s. I also believe he is carefully lining up PDD OLE and AD scrubbed data to be released right at or after Excellence trial end. With him emphasising the desire for the voucher recently and having both Rett Syndrome trials prepared and submitted he is “greasing” every possible skid available and may get much more than e expect is ALL data is great!

All in all just staying patient with these low pps movements

AIMHO